Status:
TERMINATED
Pilot Study of Colon Cancer Screening Tests
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
McMaster University
Conditions:
Colorectal Cancer
Colon Cancer
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
Colon cancer is the second leading cause of cancer death in North America. These deaths are preventable with proper screening. Fecal occult blood testing, virtual colonoscopy, and standard (optical) c...
Eligibility Criteria
Inclusion
- All individuals age 50 to 70 years
Exclusion
- Unable to give informed consent
- History of colorectal cancer
- History of adenomatous polyp
- History of inflammatory bowel disease
- Prior participation in FOBT screening
- Prior refusal to participate in FOBT screening
- Flexible sigmoidoscopy within the previous 3 years
- Virtual colonoscopy within the previous 3 years
- Optical colonoscopy within the previous 3 years
- Severe of terminal illness that would preclude benefit from colon cancer screening
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT00865527
Start Date
March 1 2010
End Date
September 1 2011
Last Update
March 31 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences
Hamilton, Ontario, Canada, L8N 3Z5